David Jacobs

Chief Development Officer at Oculis

Dr. Jacobs brings to Oculis more than 20 years of leadership experience in drug development. He joins us from Osmotica Pharmaceuticals, where he was Vice-President of Clinical Development and Medical Affairs since 2017. During his tenure, in addition to leading the clinical programs from phase I to IV in several therapeutic areas including ophthalmology, he was a key contributor to successful FDA submissions and market approvals, a key experience. Prior to his role at Osmotica, Dr. Jacobs held drug development leadership roles at Daiichi-Sankyo Pharmaceuticals, Aptalis Pharmaceuticals, Johnson & Johnson and King Pharmaceuticals.

Location

New York, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Oculis

1 followers

Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back-and front-of-the-eye in order to improve the sight and the lives of patients worldwide.


Industries

Employees

11-50

Links